Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2006-02-01
2010-11-16
Berch, Mark L (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C544S276000
Reexamination Certificate
active
07834181
ABSTRACT:
Hsp90 inhibitors are provided having the formula:with a 2′,4′,5′-substitution pattern on the right-side aryl moiety. X1represents two substituents, which may be the same or different, disposed in the 4′ and 5′ positions on the aryl group, wherein X1is selected from halogen, alkyl, alkoxy, halogenated alkoxy, hydroxyalkyl, pyrollyl, optionally substituted aryloxy, alkylamino, dialkylamino, carbamyl, amido, alkylamido dialkylamido, acylamino, alkylsulfonylamido, trihalomethoxy, trihalocarbon, thioalkyl, SO2−alkyl, COO-alkyl, KH2, OH, CN, SO2X5, NO2, NO, C═SR2NSO2X5, C═OR2, where X5is F, NH2, alkyl or H, and R2is alkyl, NH2, NH-alkyl or O-alkyl, C1to C6alkyl or alkoxy; or wherein X1has the formula —O—(CH2)n—O—, wherein n is an integer from 0 to 2, preferably 1 or 2, and one of the oxygen is bonded at the 5′-position and the other at the 4′-position of the aryl ring. The compounds are useful in cancer therapy and as radioimaging ligands.
REFERENCES:
patent: 7241890 (2007-07-01), Kasibhatla et al.
patent: 7439359 (2008-10-01), Chiosis et al.
patent: 7595401 (2009-09-01), Bajji et al.
patent: 2004/0102458 (2004-05-01), Chiosis et al.
patent: 2005/0049263 (2005-03-01), Kasibhatla et al.
patent: 2007/0299258 (2007-12-01), Bajji et al.
patent: 2008/0096903 (2008-04-01), Chen et al.
patent: 2008/0221132 (2008-09-01), Cai et al.
patent: 2008/0234297 (2008-09-01), Qian et al.
patent: 2008/0234314 (2008-09-01), Cai et al.
patent: 2009/0298857 (2009-12-01), Chiosis et al.
patent: 96/32480 (1996-10-01), None
patent: 96/40789 (1996-12-01), None
patent: 97/04801 (1997-02-01), None
patent: 02/36705 (2002-05-01), None
patent: 03/037860 (2003-05-01), None
patent: 2005/012482 (2005-02-01), None
patent: 2006130469 (2006-12-01), None
patent: WO 2006130469 (2006-12-01), None
patent: WO 2007014323 (2007-02-01), None
patent: 2007117466 (2007-10-01), None
patent: WO 2007117466 (2007-10-01), None
patent: 2008013985 (2008-01-01), None
patent: 2008056120 (2008-05-01), None
patent: 2008070472 (2008-06-01), None
patent: 2009007399 (2009-01-01), None
patent: 2009042646 (2009-04-01), None
patent: 2009065035 (2009-05-01), None
He, Huazhong et al. “Identification of Potent Water Soluble Purine-Scaffold Inhibitors of the Heat Shock Protein 90” 2006, pp. 381-390, vol. 49, J. Med. Chem.
Chiosis, Gabriela et al. “Development of a Purine-Scaffold Novel Class of Hsp90 Binders that Inhibit the Proliferation of Cancer Cells and Induce the Degradation of Her2 Tyrosine Kinase”, Nov. 2002, pp. 3555-3564, vol. 10, Issue 11, Bioorganic & Medicinal Chemistry.
Llauger, Laura et al. “Synthesis of 8-arylsulfoxyl/sulfonyl adenines”, Dec. 20, 2004, pp. 9594-9552, vol. 45, Issue 52.
Llauger, Laura et el. “Evaluation of 8-Arylsulfanyl, 8-Arylsulfoxy, and 8-Arylsulfonyl Adenine Derivatives as Inhibitors of the Heat Shock Protein 90”, Mar. 25, 2005, pp. 2892-2905, vol. 48, Issue 8, J. Med. Chem.
Lucas, Brian et al. “Facile Synthesis of a Library of 9-Alkyl-8-benzyl-9H-purin-6-ylamine Derivatives”, Sep. 21, 2001, pp. 518-520, vol. 3, J. Comb Chem.
Chiosis Gabriela
He Huazhong
Kim Joungnam
Larson Steve M.
Llauger-Bufi Laura
Berch Mark L
Larson & Anderson LLC
Slaon-Kettering Institute for Cancer Research
LandOfFree
Small-molecule Hsp90 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Small-molecule Hsp90 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small-molecule Hsp90 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4152526